Controversies Conference on Blood Pressure in Chronic Kidney Disease – Stage 5D

New York City, USA March, 2009

Back to All Controversies Conferences

This conference, attended by 50 international experts, was designed to promote active dialogue regarding the etiology, assessment, consequences and management of abnormal blood pressure in patients receiving dialysis. The discussion and recommendations from the conference will helped to focus the development of the KDIGO Guideline on Management of Blood Pressure in CKD.

Plenary session presentations

Hypertension, diabetes, chronic kidney disease and carotid-intima media damage; methods for identification, prophylaxis and management. Blood vessel damage and hypertension; how best to assess endothelial dysfunction?

Presenter: Gérard London

What is known from clinical trials about optimal drug management of hypertension in CKD Stage V – the role of beta blockers, and various forms of inhibition of the RAAS?

Presenter: Hermann Haller

How best to control salt overload in hypertension? Dietetic? Aligning dialysate sodium with patient’s serum sodium, prohibition of sodium profiling

Presenter: Ken Farrington

Hypertension and raised hematocrit, relationship to EPO and volume contraction

Presenter: Kai-Uwe Eckardt

Hypertension and sleep apnea in CKD Stage 5

Presenter: Chris Chan